In September 2017, Nestlé announced that it would be closing its Galderma-Spirig site in Egerkingen. This site will now be given a new lease of life by Omya International, which is based in neighbouring Oftringen AG. It will take on the property in full, including all buildings and facilities, Omya International revealed in a press release. The producer of industrial minerals will be moving all research and development activities here. In addition, Omya intends to acquire the Cosmospheres business unit from Spirig Pharma. Spirig is part of Nestlé Skin Health S.A. and is primarily engaged in the field of dermatics.
Omya’s headquarters in Oftringen have grown strongly in recent years and have reached their capacity, the company reported. By relocating to the buildings already available at the Galderma-Spirig, the company can eliminate bottleneck at its headquarters “long-term without further construction and space will be made available for the company's strongly growing activities”.
Federal Councillor for Solothurn Brigit Wysst commented that this "acquisition of the Galderma-Spirig site by Omya International is great news for the canton of Solothurn and the municipality of Egerkingen. This allows the canton of Solothurn to greatly strengthen its position in the life sciences sector”.
More News
Contact us
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?
info@greaterzuricharea.com